Alcohol-induced metabolomic differences in humans

M. Jaremek, Z. Yu, M. Mangino, K. Mittelstrass, C. Prehn, P. Singmann, T. Xu, N. Dahmen, K. M. Weinberger, Karsten Suhre, A. Peters, A. Döring, H. Hauner, J. Adamski, T. Illig, T. D. Spector, R. Wang-Sattler

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Alcohol consumption is one of the world's major risk factors for disease development. But underlying mechanisms by which moderate-to-heavy alcohol intake causes damage are poorly understood and biomarkers are sub-optimal. Here, we investigated metabolite concentration differences in relation to alcohol intake in 2090 individuals of the KORA F4 and replicated results in 261 KORA F3 and up to 629 females of the TwinsUK adult bioresource. Using logistic regression analysis adjusted for age, body mass index, smoking, high-density lipoproteins and triglycerides, we identified 40/18 significant metabolites in males/females with P-values <3.8E-04 (Bonferroni corrected) that differed in concentrations between moderate-to-heavy drinkers (MHD) and light drinkers (LD) in the KORA F4 study. We further identified specific profiles of the 10/5 metabolites in males/females that clearly separated LD from MHD in the KORA F4 cohort. For those metabolites, the respective area under the receiver operating characteristic curves were 0.812/0.679, respectively, thus providing moderate-to-high sensitivity and specificity for the discrimination of LD to MHD. A number of alcohol-related metabolites could be replicated in the KORA F3 and TwinsUK studies. Our data suggests that metabolomic profiles based on diacylphosphatidylcholines, lysophosphatidylcholines, ether lipids and sphingolipids form a new class of biomarkers for excess alcohol intake and have potential for future epidemiological and clinical studies.

Original languageEnglish
Article numbere276
JournalTranslational Psychiatry
Volume3
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Metabolomics
Alcohols
Biomarkers
Lysophosphatidylcholines
Sphingolipids
HDL Lipoproteins
ROC Curve
Alcohol Drinking
Ether
Epidemiologic Studies
Body Mass Index
Logistic Models
Smoking
Regression Analysis
Lipids
Sensitivity and Specificity

Keywords

  • alcohol
  • alcoholism
  • biomarkers
  • gender
  • lipids
  • metabolomics

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Jaremek, M., Yu, Z., Mangino, M., Mittelstrass, K., Prehn, C., Singmann, P., ... Wang-Sattler, R. (2013). Alcohol-induced metabolomic differences in humans. Translational Psychiatry, 3, [e276]. https://doi.org/10.1038/tp.2013.55

Alcohol-induced metabolomic differences in humans. / Jaremek, M.; Yu, Z.; Mangino, M.; Mittelstrass, K.; Prehn, C.; Singmann, P.; Xu, T.; Dahmen, N.; Weinberger, K. M.; Suhre, Karsten; Peters, A.; Döring, A.; Hauner, H.; Adamski, J.; Illig, T.; Spector, T. D.; Wang-Sattler, R.

In: Translational Psychiatry, Vol. 3, e276, 2013.

Research output: Contribution to journalArticle

Jaremek, M, Yu, Z, Mangino, M, Mittelstrass, K, Prehn, C, Singmann, P, Xu, T, Dahmen, N, Weinberger, KM, Suhre, K, Peters, A, Döring, A, Hauner, H, Adamski, J, Illig, T, Spector, TD & Wang-Sattler, R 2013, 'Alcohol-induced metabolomic differences in humans', Translational Psychiatry, vol. 3, e276. https://doi.org/10.1038/tp.2013.55
Jaremek M, Yu Z, Mangino M, Mittelstrass K, Prehn C, Singmann P et al. Alcohol-induced metabolomic differences in humans. Translational Psychiatry. 2013;3. e276. https://doi.org/10.1038/tp.2013.55
Jaremek, M. ; Yu, Z. ; Mangino, M. ; Mittelstrass, K. ; Prehn, C. ; Singmann, P. ; Xu, T. ; Dahmen, N. ; Weinberger, K. M. ; Suhre, Karsten ; Peters, A. ; Döring, A. ; Hauner, H. ; Adamski, J. ; Illig, T. ; Spector, T. D. ; Wang-Sattler, R. / Alcohol-induced metabolomic differences in humans. In: Translational Psychiatry. 2013 ; Vol. 3.
@article{bb26fa6953f24cf0a5a771c63d217f7a,
title = "Alcohol-induced metabolomic differences in humans",
abstract = "Alcohol consumption is one of the world's major risk factors for disease development. But underlying mechanisms by which moderate-to-heavy alcohol intake causes damage are poorly understood and biomarkers are sub-optimal. Here, we investigated metabolite concentration differences in relation to alcohol intake in 2090 individuals of the KORA F4 and replicated results in 261 KORA F3 and up to 629 females of the TwinsUK adult bioresource. Using logistic regression analysis adjusted for age, body mass index, smoking, high-density lipoproteins and triglycerides, we identified 40/18 significant metabolites in males/females with P-values <3.8E-04 (Bonferroni corrected) that differed in concentrations between moderate-to-heavy drinkers (MHD) and light drinkers (LD) in the KORA F4 study. We further identified specific profiles of the 10/5 metabolites in males/females that clearly separated LD from MHD in the KORA F4 cohort. For those metabolites, the respective area under the receiver operating characteristic curves were 0.812/0.679, respectively, thus providing moderate-to-high sensitivity and specificity for the discrimination of LD to MHD. A number of alcohol-related metabolites could be replicated in the KORA F3 and TwinsUK studies. Our data suggests that metabolomic profiles based on diacylphosphatidylcholines, lysophosphatidylcholines, ether lipids and sphingolipids form a new class of biomarkers for excess alcohol intake and have potential for future epidemiological and clinical studies.",
keywords = "alcohol, alcoholism, biomarkers, gender, lipids, metabolomics",
author = "M. Jaremek and Z. Yu and M. Mangino and K. Mittelstrass and C. Prehn and P. Singmann and T. Xu and N. Dahmen and Weinberger, {K. M.} and Karsten Suhre and A. Peters and A. D{\"o}ring and H. Hauner and J. Adamski and T. Illig and Spector, {T. D.} and R. Wang-Sattler",
year = "2013",
doi = "10.1038/tp.2013.55",
language = "English",
volume = "3",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Alcohol-induced metabolomic differences in humans

AU - Jaremek, M.

AU - Yu, Z.

AU - Mangino, M.

AU - Mittelstrass, K.

AU - Prehn, C.

AU - Singmann, P.

AU - Xu, T.

AU - Dahmen, N.

AU - Weinberger, K. M.

AU - Suhre, Karsten

AU - Peters, A.

AU - Döring, A.

AU - Hauner, H.

AU - Adamski, J.

AU - Illig, T.

AU - Spector, T. D.

AU - Wang-Sattler, R.

PY - 2013

Y1 - 2013

N2 - Alcohol consumption is one of the world's major risk factors for disease development. But underlying mechanisms by which moderate-to-heavy alcohol intake causes damage are poorly understood and biomarkers are sub-optimal. Here, we investigated metabolite concentration differences in relation to alcohol intake in 2090 individuals of the KORA F4 and replicated results in 261 KORA F3 and up to 629 females of the TwinsUK adult bioresource. Using logistic regression analysis adjusted for age, body mass index, smoking, high-density lipoproteins and triglycerides, we identified 40/18 significant metabolites in males/females with P-values <3.8E-04 (Bonferroni corrected) that differed in concentrations between moderate-to-heavy drinkers (MHD) and light drinkers (LD) in the KORA F4 study. We further identified specific profiles of the 10/5 metabolites in males/females that clearly separated LD from MHD in the KORA F4 cohort. For those metabolites, the respective area under the receiver operating characteristic curves were 0.812/0.679, respectively, thus providing moderate-to-high sensitivity and specificity for the discrimination of LD to MHD. A number of alcohol-related metabolites could be replicated in the KORA F3 and TwinsUK studies. Our data suggests that metabolomic profiles based on diacylphosphatidylcholines, lysophosphatidylcholines, ether lipids and sphingolipids form a new class of biomarkers for excess alcohol intake and have potential for future epidemiological and clinical studies.

AB - Alcohol consumption is one of the world's major risk factors for disease development. But underlying mechanisms by which moderate-to-heavy alcohol intake causes damage are poorly understood and biomarkers are sub-optimal. Here, we investigated metabolite concentration differences in relation to alcohol intake in 2090 individuals of the KORA F4 and replicated results in 261 KORA F3 and up to 629 females of the TwinsUK adult bioresource. Using logistic regression analysis adjusted for age, body mass index, smoking, high-density lipoproteins and triglycerides, we identified 40/18 significant metabolites in males/females with P-values <3.8E-04 (Bonferroni corrected) that differed in concentrations between moderate-to-heavy drinkers (MHD) and light drinkers (LD) in the KORA F4 study. We further identified specific profiles of the 10/5 metabolites in males/females that clearly separated LD from MHD in the KORA F4 cohort. For those metabolites, the respective area under the receiver operating characteristic curves were 0.812/0.679, respectively, thus providing moderate-to-high sensitivity and specificity for the discrimination of LD to MHD. A number of alcohol-related metabolites could be replicated in the KORA F3 and TwinsUK studies. Our data suggests that metabolomic profiles based on diacylphosphatidylcholines, lysophosphatidylcholines, ether lipids and sphingolipids form a new class of biomarkers for excess alcohol intake and have potential for future epidemiological and clinical studies.

KW - alcohol

KW - alcoholism

KW - biomarkers

KW - gender

KW - lipids

KW - metabolomics

UR - http://www.scopus.com/inward/record.url?scp=84880113662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880113662&partnerID=8YFLogxK

U2 - 10.1038/tp.2013.55

DO - 10.1038/tp.2013.55

M3 - Article

VL - 3

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

M1 - e276

ER -